Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PRMEPRME
11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PRIME MEDICINE INC

CITADEL ADVISORS LLC holds 2.1M shares of PRME (PRIME MEDICINE INC), worth $7.6M as of 2026-Q2. The position was increased (+510.8% shares). PRME represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$7.6M

Current Shares

2.1M

Total Value Change

+$7.5M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+510.8%
$7.6M0.0%$3.69
44
2026-Q1
Increased
336,358
+198.0%
$1.2M0.0%$4.23
41
2025-Q4
Decreased
112,870
-87.5%
$391,6590.0%$3.44
0
2025-Q3
Increased
900,142
+72.6%
$5M0.0%$5.32
40
2025-Q2
New
521,508
-
$1.3M0.0%$2.42
35
2024-Q4
Exited
0
-100.0%
$00.0%$2.78
0
2024-Q3
Increased
50,995
+300.7%
$197,3510.0%$3.46
25
2024-Q2
Decreased
12,726
-88.2%
$65,4120.0%$5.14
0
2024-Q1
New
108,198
-
$757,3860.0%$7.00
34
2023-Q4
Exited
0
-100.0%
$00.0%$8.86
0
2023-Q3
New
6,524
-
$62,2390.0%$9.54
32

Other major holders of PRME: Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used